Loading fund…
Loading fund…
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | ▲ +3.7% | ▼ −1.5% | ▼ −17.0% | ▲ +27.5% | ▲ +86.5% | ▲ +192.0% | ▼ −11.6% | ▼ −29.0% |
| Peer average | ▲ +0.4% | ▲ +0.2% | ▼ −4.6% | ▲ +19.4% | ▲ +21.0% | ▲ +170.6% | ▲ +15.0% | — |
| S&P 500 · VOO | ▼ −0.4% | ▲ +0.9% | ▲ +3.3% | ▲ +13.8% | ▲ +13.3% | ▲ +88.8% | ▲ +81.9% | — |
Reported holdings are shown below. A share-of-fund chart is unavailable for this portfolio.
Holdings as of 2026-10-30. Derivatives are shown using their reported instrument names.
| Holding | Instrument | Weight |
|---|---|---|
| SPSIPH SWAP ASSET LEG (SPSIPHCTL) | swap | 32.67% |
| SPSIPH SWAP ASSET LEG (SPSIPHBCL) | swap | 19.02% |
| SPSIPH SWAP ASSET LEG (SPSIPHUBL) | swap | 16.33% |
| GOLDMAN FINL SQ TRSRY INST 506 | Reported holding | 5.65% |
| SPSIPH SWAP ASSET LEG (SPSIPHJPL) | swap | 2.78% |
| DREYFUS GOVT CASH MAN INS | Reported holding | 1.60% |
| GOLDMAN SACHS FIN GOV 465 INSTITUT | Reported holding | 1.32% |
| MANEVERADERMICS INC | Reported holding | 0.59% |
| XERSXERIS BIOPHARMA HOLDINGS INC | Reported holding | 0.57% |
| PCRXPACIRA BIOSCIENCES INC | Reported holding | 0.52% |
| AMRXAMNEAL PHARMACEUTICALS INC | Reported holding | 0.51% |
| LLYELI LILLY & CO | Reported holding | 0.50% |
| VTRSVIATRIS INC | Reported holding | 0.48% |
| MAZEMAZE THERAPEUTICS INC | Reported holding | 0.47% |
| SEPNSEPTERNA INC | Reported holding | 0.46% |
| PRGOPERRIGO CO PLC | Reported holding | 0.45% |
| LGNDLIGAND PHARMACEUTICALS | Reported holding | 0.45% |
| RPRXROYALTY PHARMA PLC- CL A | Reported holding | 0.45% |
| PFEPFIZER INC | Reported holding | 0.44% |
| ZTSZOETIS INC | Reported holding | 0.44% |
| ANIPANI PHARMACEUTICALS INC | Reported holding | 0.42% |
| JNJJOHNSON & JOHNSON | Reported holding | 0.42% |
| INDVINDIVIOR PHARMACEUTICALS INC | Reported holding | 0.41% |
| OGNORGANON & CO | Reported holding | 0.41% |
| INVAINNOVIVA INC | Reported holding | 0.41% |
| COLLCOLLEGIUM PHARMACEUTICAL INC | Reported holding | 0.41% |
| PBHPRESTIGE CONSUMER HEALTHCARE | Reported holding | 0.41% |
| DFTXDEFINIUM THERAPEUTICS INC | Reported holding | 0.41% |
| SUPNSUPERNUS PHARMACEUTICALS INC | Reported holding | 0.41% |
| MRKMERCK & CO. INC. | Reported holding | 0.41% |
PILL seeks to deliver investment results of 3x the daily performance of the S&P Pharmaceuticals Select Industry Index, a modified equal-weighted index that measures the performance of pharmaceutical companies, as defined by GICS, on the S&P Total Market Index. The fund uses derivatives and swaps to achieve its target exposure. As a levered product with daily resets, PILL is designed as a short-term trading tool and not a long-term investment vehicle. As a result, long-term returns could materially differ from those of the underlying index due to daily compounding. Prior to August 2, 2019, the fund aimed to provide 3x leveraged exposure to the Dynamic Pharmaceutical Intellidex Index. Effective February 27, 2026, the fund replaced the term Shares in its name with ETF.
Distribution yield and SEC yield use different methodologies. Payouts may include income, capital gains, or return of capital.
| Ex-date | Pay date | Per share |
|---|---|---|
| 2026-09-22 | 2026-09-29 | $0.00 |
| 2026-06-23 | 2026-06-30 | $0.02 |
| 2026-03-24 | 2026-03-31 | $0.01 |
| 2025-12-23 | 2025-12-31 | $0.03 |
| 2025-09-23 | 2025-09-30 | $0.01 |
| 2025-06-24 | 2025-07-01 | $0.02 |
| 2025-03-25 | 2025-04-01 | $0.02 |
| 2024-12-23 | 2024-12-31 | $0.01 |
| 2024-09-24 | 2024-10-01 | $0.03 |
| 2024-06-25 | 2024-07-02 | $0.02 |
| 2024-03-19 | 2024-03-26 | $0.03 |
| 2023-12-21 | 2023-12-29 | $0.04 |
Estimated annual expense excludes trading costs and assumes constant assets. Fee waivers and fund costs can change.
Historical risk measures describe past behavior and do not predict future returns.
Hear the strategy from the people behind PILL.